The melanogenesis and mechanisms of skin-lightening agents - existing and new approaches

被引:290
作者
Gillbro, J. M. [1 ]
Olsson, M. J. [1 ]
机构
[1] Oriflame Cosmet Skin Res Inst, SE-10139 Stockholm, Sweden
关键词
adrenergic; melanogenesis; skin lightening; tyrosinase; vitiligo; MELANOCYTE-STIMULATING HORMONE; MICROPHTHALMIA GENE-PRODUCT; HUMAN EPIDERMAL MELANOCYTES; TYROSINASE-RELATED PROTEIN; CULTURED HUMAN MELANOCYTES; TRANS-RETINOIC ACID; TRANSCRIPTION FACTOR; HUMAN KERATINOCYTES; GLYCOLIC ACID; IN-VITRO;
D O I
10.1111/j.1468-2494.2010.00616.x
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Synopsis Skin-lightening products are commercially available for cosmetic purposes to obtain lighter skin complexion. Clinically, they are also used for treatment of hyperpigmentary disorders such as melasma, cafe au lait spot and solar lentigo. All of these target naturally melanin production, and many of the commonly used agents are known as competitive inhibitors of tyrosinase, one of the key enzymes in melanogenesis. In this review, we present an overview of commonly used skin-whitening ingredients that are commercialized, but we also hypothesize on other mechanisms that could be important targets to control skin pigmentation such as for example regulation of the adrenergic and glutaminergic signalling and also control of tetrahydrobiopterins in the human skin.Resume Les produits eclaircissants sont disponibles dans le commerce pour des buts cosmetiques afin d'obtenir un tient plus clair. Ils sont egalement utilises en clinique, pour le traitement de troubles hyper pigmentaires comme le melasma, les taches cafe au lait et le lentigo solaire. Tous ces produits ont pour cible la production naturelle de melanine et beaucoup de ceux generalement utilises sont reconnus comme des inhibiteurs competitifs de la tyrosinase, une des enzymes cles de la melanogenese. Dans cette revue, nous presentons une vue d'ensemble des ingredients generalement utilises et commercialises comme blanchissant cutanes mais nous formulons aussi l'hypothese que d'autres mecanismes pourraient etre des cibles importantes pour controler la pigmentation de la peau comme par exemple la regulation du signal adrenergique et glutaminergique ou le controle des tetrahydrobiopterines dans la peau humaine.
引用
收藏
页码:210 / 221
页数:12
相关论文
共 142 条
[71]   ISOLATION AND SEQUENCE OF A CDNA CLONE FOR HUMAN TYROSINASE THAT MAPS AT THE MOUSE C-ALBINO LOCUS [J].
KWON, BS ;
HAQ, AK ;
POMERANTZ, SH ;
HALABAN, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7473-7477
[72]   INTERACTION BETWEEN CHEMICALS AND MELANIN [J].
LARSSON, BS .
PIGMENT CELL RESEARCH, 1993, 6 (03) :127-133
[73]  
Lemic-Stojcevic L, 1995, Exp Dermatol, V4, P79, DOI 10.1111/j.1600-0625.1995.tb00226.x
[74]   MELANOCYTE-STIMULATING HORMONE + ADRENOCORTICOTROPHIC HORMONE - THEIR RELATION TO PIGMENTATION [J].
LERNER, AB ;
MCGUIRE, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1964, 270 (11) :539-&
[75]   EFFECT OF ALPHA- AND BETA-MELANOCYTE STIMULATING HORMONES ON SKIN COLOUR OF MAN [J].
LERNER, AB ;
MCGUIRE, JS .
NATURE, 1961, 189 (476) :176-&
[76]   MSH - THE MELANOCYTE-STIMULATING HORMONE [J].
LERNER, AB ;
SHIZUME, K ;
FITZPATRICK, TB ;
MASON, HS .
AMA ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1954, 70 (05) :669-674
[77]   INDUCTION OF SKIN TANNING BY SUBCUTANEOUS ADMINISTRATION OF A POTENT SYNTHETIC MELANOTROPIN [J].
LEVINE, N ;
SHEFTEL, SN ;
EYTAN, T ;
DORR, RT ;
HADLEY, ME ;
WEINRACH, JC ;
ERTL, GA ;
TOTH, K ;
MCGEE, DL ;
HRUBY, VJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (19) :2730-2736
[78]   Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation [J].
Lin, CB ;
Babiarz, L ;
Liebel, F ;
Roydon Price, E ;
Kizoulis, M ;
Gendimenico, GJ ;
Fisher, DE ;
Seiberg, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (06) :1330-1340
[79]   Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients [J].
Lowe, NJ ;
Rizk, D ;
Grimes, P ;
Billips, M ;
Pincus, S .
CLINICAL THERAPEUTICS, 1998, 20 (05) :945-959
[80]  
Maeda K, 1996, J PHARMACOL EXP THER, V276, P765